Pharmabiz

TN leads IPC delegate count as Bengaluru gears up for 74th IPC to be held from Dec 19-21

Peethaambaran Kunnathoor, Chennai Wednesday, December 10, 2025, 08:00 Hrs [IST] ...
Pharmabiz

Indian ophthalmology players work to align eye care with vision of Viksit Bharat 2047

Indian ophthalmology players work to align eye care with vision of Viksit Bharat 2047: Nandita Vijayasimha, Bengaluru Wednesday, December 10, 2025, 08:00 Hrs [IST] India is mappin ...
Pharmabiz

PCI asks State Councils to issue registration to D.Pharm students of 2022-23 batch

PCI asks State Councils to issue registration to D.Pharm students of 2022-23 batch: Gireesh Babu, New Delhi Wednesday, December 10, 2025, 08:00 Hrs [IST] The Pharmacy Council of I ...
Pharmabiz

CDSCO releases MedTech Mitra's handbook for innovators in IVD medical devices segment

CDSCO releases MedTech Mitra's handbook for innovators in IVD medical devices segment: Our Bureau, New Delhi Wednesday, December 10, 2025, 08:00 Hrs [IST] The Central Drugs Standa ...
Pharmabiz

GROWING GRAPH OF IP

This MoU will establish a framework for the recognition of the IP as a pharmacopoeia standard for assessing applications for market authorisation for medicinal products manufactured in India. Thus, it ...
Pharmabiz

Emcutix Biopharma introduces SOLGLO-AZ liposomal serum for hyperpigmentation in India

Emcutix Biopharma introduces SOLGLO-AZ liposomal serum for hyperpigmentation in India: Our Bureau, Mumbai Tuesday, December 9 ...
Pharmabiz

Medi Mold inks pact with OIC Intl. invests Rs. 100+ crore to set up 3D-printed orthopaedic implants production unit in Vizag

Medi Mold inks pact with OIC Intl. invests Rs. 100+ crore to set up 3D-printed orthopaedic implants production unit in Vizag: Our Bureau, Bengaluru Tuesday, December 9, 2025, 17:1 ...
Pharmabiz

UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduces CMSF in CDKL5 deficiency disorder

UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduces CMSF in CDKL5 deficiency disorder: Brussels, Belgium Tuesday, December 9, 2 ...
Pharmabiz

Metropolis granted patent for a clinician-friendly decision support system to transform TB detection and management

Metropolis granted patent for a clinician-friendly decision support system to transform TB detection and management: Our Bureau, Bengaluru Tuesday, December 9, 2025, 14:30 Hrs [IS ...
Pharmabiz

Ouro Medicines’ BCMAxCD3 T cell engager antibody candidate, gamgertamig gets US FDA orphan drug designation to treat immune thrombocytopenia

Ouro Medicines’ BCMAxCD3 T cell engager antibody candidate, gamgertamig gets US FDA orphan drug designation to treat immune thrombocytopenia: South San Francisco Tuesday, Decemb ...
Pharmabiz

Boehringer Ingelheim advances next generation triple-agonist peptide for the treatment of obesity into mid-stage development

Boehringer Ingelheim advances next generation triple-agonist peptide for the treatment of obesity into mid-stage development: Ingelheim, Germany Tuesday, December 9, 2025, 09:00 H ...
Pharmabiz

Mirum Pharma inks agreement to acquire biotech company, Bluejay Therapeutics for up to $820 million

Mirum Pharma inks agreement to acquire biotech company, Bluejay Therapeutics for up to $820 million: Foster City, California Tuesday, December 9, 2025, 14:00 Hrs [IST] Mirum Pharm ...